ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 109451 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 109451; 2) Community: the network communities that were significantly associated with the response to NSC 109451; 3) Molecule: the relationships between components within communities and NSC 109451; 4) MDR: the compounds that were significantly associated with the NSC 109451.

NSC Compound Enrichment Correlation
NSC 191909 .alpha.-Chloro-N-(p-methoxyphenyl)succinimide 0.0467178916101842 -0.10295095
NSC 212446 Null 0.0467178916101842 -0.1868029
NSC 3091 Ammonium, [.alpha.-[p-(dimethylamino)phenyl]-.alpha.-[4-(dimethyliminio)-2,5-cyclohexadien-1-ylidene]-p-tolyl]ethyldimethyl-, bromide, chloride (8CI) 0.0467178916101842 -0.054989957
NSC 356777 2-Propen-1-one, 3-(4-chlorophenyl)-1-(1-hydroxy-7-oxo- 1,3,5-cycloheptriene-2-yl)- 0.0467178916101842 -0.21746047
NSC 362454 4-Pyridazinecarbonitrile, 5,6-bis(4-fluorophenyl)-2,3-dihydro-2-(2-hydroxyethyl)-3-oxo- 0.0467178916101842 -0.040339214
NSC 381866 BAFILOMYCIN DERIV. 0.0467178916101842 -0.17403339
NSC 44580 9H-Purin-2-amine, 6-[[(2-chlorophenyl)methyl]thio]-9-propyl- 0.0467178916101842 -0.13583575
NSC 602610 Null 0.0467178916101842 -0.2020623
NSC 606698 Rapamycin prodrug, Mono-(28)-N,N-dimethylglycinate-, methanesulfonic acid salt 0.0467178916101842 0.30350192
NSC 621376 Null 0.0467178916101842 -0.39298663
Total:114  Current:109    [First] [Prev] [Next] [Last]